-
CVS Well being, Sandoz companion on low cost Humira biosimilar
Rafael Henrique | Lightrocket | Getty Images CVS Health is partnering with drugmaker Sandoz to produce a near identical version of the blockbuster arthritis treatment Humira that will sell for 80% below the price of the brand-named drug. The move is part of the company’s new venture focused on securing, and in some cases co-producing,…
-
Key Witness Recanted False Testimony And Implicated Trump
Trump Employee 4 who is a key witness in the classified documents case recanted his previous false testimony after Trump’s effort to destroy video surveillance footage after he dumped a Trump paid for attorney and got a new lawyer. According to page 4 of the filing: District Court for District of Columbia (Boasberg, C.J.), who…
-
Jaylan Banks Seeks Full Custody Amid Falynn Pina’s DV Claims
On Sunday (Aug. 20), Jaylan Banks revealed he filed for full custody of his daughter Emma against ex-girlfriend Falynn Pina, he exclusively told The Shade Room. Banks submitted paperwork via Odyssey eFileGA, categorized mandatory for e-filing for Fulton County State and Superior Court on Gerogia’s Judicial Council website. A screenshot of the online filing classified it…
-
Some lawmakers need to improve the 1099-Ok tax reporting thresholds
As the year-end approaches, there’s been debate around tax reporting for business transactions on payment apps such as Venmo and PayPal, along with e-commerce companies, such as eBay, Etsy and Poshmark. Some lawmakers are pushing to increase the IRS reporting threshold for Form 1099-K, which covers third-party business payments. Taxpayers who use a payment app to process transactions for…
-
Can costly, American-made weapons like F-16s flip the tide in Ukraine’s battle in opposition to Russia?
The Ukrainian counteroffensive that launched in June against Moscow’s invasion has run into a Russian wall. In the run-up to the Ukrainian push, weapons from Western allies — such as tanks, artillery and other equipment — poured into Ukraine. Despite some small gains, Ukrainian forces have yet to see a large breakthrough, leaving some to…
-
New vaccines will possible defend in opposition to Eris variant
A pharmacist prepares to administer Covid-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center in Chicago, Illinois, Sept. 9, 2022. Scott Olson | Getty Images New Covid vaccines from Pfizer, Moderna and Novavax will likely provide protection against the new “Eris” variant, now the…
-
Prime GOP voice on China menace says funding restrictions fall quick
WASHINGTON — A leading House Republican voice on the national security threat posed by China said the White House’s plan to restrict outbound investment in the Chinese military and defense companies falls short of addressing the real problem. President Joe Biden’s executive order, which is expected to be implemented next year, “takes an important step…
-
TJX Firms (TJX) earnings Q2 2024
Shoppers at a TJ Maxx store in New York. Scott Mlyn | CNBC Cash-strapped consumers may be pulling back on discretionary purchases at Target, but they’re spending big on name brands and home goods at off-price TJX Cos. The discounter raised its full-year outlook on Wednesday after posting a 7.7% year-over-year sales jump and a…
-
Tuohy Household Lawyer Slams Michael Oher’s Lawsuit as “Shakedown Effort”
Sean and Leigh Anne Tuohy‘s lawyer is calling a foul on Michael Oher‘s lawsuit. Marty Singer, who is representing the couple in the case, fired back at the former NFL star’s allegations that the family had lied about adopting him and subsequently made millions from his story, which was the basis of the 2009 movie The Blind Side. Singer…
-
Jim Cramer talks about his ‘favourite inventory,’ telling buyers to purchase some
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks rose Monday, though they’re still having a rough August. Nvidia (NVDA), which has been slumping recently, jumped about 5.5% to start the week. Morgan Stanley reiterated Nvidia…